Revance Therapeutics, Inc.

Revance Therapeutics — Merger or Acquisition (May 2020)

28 slides from Revance Therapeutics's merger presentation, May 19, 2020

  1. Slide 1: Powering Prestige Experiences in Aesthetics: Revance Acquisition of HintMD

    Powering Prestige Experiences in Aesthetics with Products and Services Portfolio Revance Acquisition of May 19, 2020Powering Prestige Experiences in Aesthetics with Products and Services Portfolio Revance Acquisition of May 19, 2020

  2. Slide 2: Forward-looking Statements / Safe Harbor / Market Data

    Forward-looking Statements / Safe Harbor / Market Data This presentation contains forward-looking statements which include, but are not limited to, statements regarding expected timing, completion and effects of the proposed transaction, the related benefits of the HintMD platform and related techno

  3. Slide 3: Acquisition would provide access to $500M+ payment services opportunity

    Acquisition would provide REVANCE access to $500M+ opportunity in payment services from $56B aesthetics annual payment processing market Data on File, IBIS, ISAPS, AmSpa 3Acquisition would provide REVANCE access to $500M+ opportunity in payment services from $56B aesthetics annual payment processing

  4. Slide 4: Strategic Acquisition Augments Product Portfolio with FinTech Platform

    Strategic Acquisition Would Augment Revance’s Strong Aesthetic Product Portfolio with Innovative FinTech Platform Powering Prestige DaxibotulinumtoxinA Practice and for Injection Patient Experiences PRODUCTS SERVICES Vertically-integrated Patient subscriptions and Advances Revance’s vision payments

  5. Slide 5: HintMD's Integrated Platform Transforms Revance's Commercial Footprint

    HintMD’s Integrated Platform Transforms Revance’s Commercial Footprint in Aesthetics Creates near-term value Leverages commercial with recurring revenue infrastructure Adds experienced fintech talent to: Aligns with Revance’s vision to • Expand our digital capabilities build a prestige aesthetics fr

  6. Slide 6: Integrated Payments Markets Overview

    INTEGRATED PAYMENTS MARKETS OVERVIEW 6INTEGRATED PAYMENTS MARKETS OVERVIEW 6

  7. Slide 7: Fintech Industry Trends: Convergence of Software & Payments

    Fintech Industry Trends: Convergence of Software & Payments Provides businesses with the tools to drive growth, scale operations and gain insights SEAMLESS INTEGRATION IMPROVE INSIGHTS GENERATE SALES STREAMLINE BUSINESS & ANALYTICS Online Booking Software Payment Acceptance Customer Retention Tools

  8. Slide 8: Vertically-Integrated Payment Platforms are Disrupting Traditional Markets

    Vertically-Integrated Payment Platforms are Disrupting Traditional Markets Restaurant Management 1 Spa & Fitness 2 Platform $1.9 Billion 2020 Valuation $4.9 Billion Acquired by Vista Partners 2019 Forbes Fintech 50 - Point-of-Sale Technology Platform - Point-of-Sale Purchases Integrated Technology P

  9. Slide 9: Prestige Patient and Practice Experience Through Integrated Payments Platform

    Delivering Prestige Patient and Practice Experience Through Vertically- Integrated Payments Platform For Aesthetic Practices Practice eCommerce/ Loyalty Logistics Rewards Patient Patient Wallet Brand Reward Lending With Practice Points + Cards Payment Patient Terminal Lending In-Practice Patient Mar

  10. Slide 10: PCI Compliance and PayFac Enable Competitive Advantage

    HintMD’s Investment in PCI Compliance* and PayFac Enables Competitive Advantage in the Aesthetics Market Payment Facilitators (PayFac) manage merchant underwriting Begin accepting PCI compliant Fraud control payments process, risk management, and immediately payment processing – enabling innovation

  11. Slide 11: Controlling More of the Payments Chain Strengthens HintMD's Offering

    Controlling More of the Payments Chain Strengthens HintMD’s Offering 2.87 – 4.35% Avg. fee per transac7on 3 0.5 - 1% Practice Cost Reseller Fees Gateway Fees Risk Management Processor Fees Card Brand Fees Issuer Fees Fees 3 0.5 - 1% 1. https://squareup.com/guides/credit-card-processing-fees-and-rate

  12. Slide 12: U.S. Market Opportunity – Aesthetics Payment Processing

    U.S. Market Opportunity – Aesthetics Payment Processing in 2019 33k Aesthetics practices in the U.S. $500+ $56 Billion Million Annual Payment Revenue Opportunity Processing Opportunity in U.S. Aesthetic Payment Services $1.7M Average revenue per year 12 Data on file, IBIS, ISAPS, AmSpaU.S. Market Op

  13. Slide 13: Physician Research Shows Strong Interest in Fintech Platform

    Physician Research Shows Strong Interest in FINTECH Platform – New Payment and Loyalty Solutions 64% 2x 90% Would consider/ ready to Increase in visits due to Value automated brand switch due to pricing or subscriptions loyalty as a major integration value driver Previously, payment solutions and br

  14. Slide 14: Overview

    OVERVIEW 14OVERVIEW 14

  15. Slide 15: From Dynamic Subscriptions to a Vertically-Integrated Payments Platform

    From Dynamic Subscriptions to a Vertically-Integrated Payments Platform Dynamic Subscriptions PC/HintMini Point-of-Sale Launched subscriptions for Launched full Released during services & skincare Point-of-Sale ASAPS 2019 Founding Hint, Inc. founded in Payments Brand Rewards Full Commercial Silicon

  16. Slide 16: HintMD Will Power Prestige Patient Experiences Today and in the Future

    HintMD will Power Prestige Patient Experiences in Aesthetic Practices Today and in the Future HINTMD Platform HINTMD Platform HINTMD Platform Pa0ent Wallet Prac0ce Custom Loyalty eCommerce Shipping HINTMD Platform HINTMD PARTNERS* Brand Loyalty Insights & Programs SUBSCRIPTIONS Analy0cs & PRACTICE H

  17. Slide 17: Simple. Seamless. Smart - Point of Sale System

    Simple. Seamless. Smart - Point of Sale System that Delivers Touchless benefits of smart payments HintMD enables practices to complete checkout with no contact needed between your patients and staff. • Front Desk Simple • In Treatment Rooms Checkout Options • Remotely Our partnership with HintMD sim

  18. Slide 18: Consumer Interest in Aesthetics Subscriptions is High

    Consumer Interest in Aesthetics Subscriptions is High Aesthetic subscriptions are broadly appealing, with an even distribution of interest across ages and incomes of aesthetics consumers patients participate interested in 33% 52% in some kind of aesthetic 1 1 subscription subscriptions 1. The Americ

  19. Slide 19: Dynamic Subscriptions - Grow Recurring Revenue

    Dynamic Subscriptions - Grow Recurring Revenue Through Increased Patient Compliance & Loyalty Provides an opportunity to create practice-centric loyalty programs 85% of practices believe subscriptions are an important/very important value driver Subscription patients visit 50-100% more frequently th

  20. Slide 20: Third-Party Integration via Open Platform

    Third-Party Integration via Open Platform Skincare Products Partner Integration • Payment processing provides access to real-time structured data Loyalty Programs enabling brand reward automation • Streamlines reconciliation and reduces burden on staff resources • Practice-level sell-through data pr

  21. Slide 21: Revenue Drivers for Revance with HintMD

    Revenue Drivers for Revance with HintMD GROWT H DRIV ERS REV ANCE OP P OR T U N IT IE S Increasing spend in the medical aesthetic industry will drive new # US practices Smart practice openings and total revenue available for processing point-of-sale (Payment % credit card Consumers will continue to

  22. Slide 22: Integration / Deal Terms

    INTEGRATION / DEAL TERMS 22INTEGRATION / DEAL TERMS 22

  23. Slide 23: HintMD Integration and Revance Future Footprint

    HintMD Integration Revance Future Footprint Access to technology talent, which will remain as a cohesive team Combines current Revance sales force with HintMD specialists as technical experts Pleasanton Synergize across commercial, (Technology) Newark G&A and non-technology functions (HQ + Operation

  24. Slide 24: Revance Commercial Launch Cadence

    Revance Commercial Launch Cadence Prestige Education and Training Consumer Digital & Program for select practices DTC Push DaxibotulinumtoxinA for Injection Anticipated PDUFA Prestige Education and Training th Nov 25 Program for select practices Q3 Q4 Q1 Q2 2020 2020 2021 2021 Build install base by

  25. Slide 25: Key Financial Highlights and Key Business Terms

    Key Financial Highlights and Key Business Terms HintMD currently installed in ~175 pilot practices 2019 Revenue $1.4M Stock-for-stock Non-cash Management team Intention to nominate business investment of 8.54 and directors subject to Co-Founder and CEO, combination million shares lockup agreements A

  26. Slide 26: Revance Financial Overview and Updated 2020 Guidance

    Revance Financial Overview and Updated 2020 Guidance Cash runway unchanged into 2023 $511M $220 to $230M Cash, cash equivalents and FY 2020 Non-GAAP 1 short-term investments Operating Expense 1. As of March 31, 2020, unaudited, See “Use of Non-GAAP Financial Measures” in press release entitled “Reva

  27. Slide 27: Daring to make a difference with products, and now services

    Daring to make a difference with products, and now services, delivering meaningful outcomes to our customers 27 27Daring to make a difference with products, and now services, delivering meaningful outcomes to our customers 27 27

  28. Slide 28: Thank You

    THANK YOU 28THANK YOU 28 Additional Information and Where to Find It Revance plans to file with the SEC, and the parties plan to furnish to the investors of HintMD, a Registration Statement on Form S-4, which will constitute a prospectus of Revance and will include an information statement of HintMD

Revance Therapeutics — Merger or Acquisition (May 2020) on 6ix